Free Trial
NYSE:RFL

Rafael Q1 2025 Earnings Results & Report

Rafael logo
$1.46 +0.03 (+1.96%)
Closing price 03:59 PM Eastern
Extended Trading
$1.46 +0.00 (+0.14%)
As of 07:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Rafael reported Q1 2025 earnings on December 11, 2024. The company reported EPS of -$0.37.

Earnings Announcement Details

Quarter
Q1 2025
Time
Before Market Opens
Conference Call
7:00 AM ET

Rafael EPS Results

Actual EPS
-$0.37
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Rafael Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

Rafael's Q4 2026 earnings is estimated for Wednesday, October 28, 2026, based on past reporting schedules, with a conference call scheduled on Tuesday, October 27, 2026 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Rafael Q1 2025 Earnings FAQ

Rafael (NYSE:RFL) reported earnings of -$0.37 per share for Q1 2025. The report was announced on Wednesday, December 11, 2024.

Rafael's next earnings date is estimated for Wednesday, October 28, 2026. MarketBeat tracks confirmed and estimated earnings dates for Rafael on the company's earnings history page.

Rafael Earnings Headlines

Contrasting Rafael (NYSE:RFL) and Innoviva (NASDAQ:INVA)
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel
Reviewing Rafael (NYSE:RFL) & vTv Therapeutics (NASDAQ:VTVT)
See More Rafael Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Rafael? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rafael and other key companies, straight to your email.

About Rafael

Rafael (NYSE:RFL) is a diversified holding company focused primarily on life sciences and real estate. Through its life sciences activities, the company has supported the development of therapies designed to address serious diseases, including cancer, with a particular emphasis on treatments that target cancer-cell metabolism.

The company’s real estate interests include commercial properties and related investments. Rafael Holdings has historically maintained a connection to Rafael Pharmaceuticals, a biotechnology company involved in oncology drug development, although its operating structure and investments may change over time.

Rafael Holdings was established as a spin-off from IDT Corporation. The company is based in the United States and serves its markets through its investment holdings rather than through a broad consumer-facing product portfolio.

View Rafael Profile